Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Fourth Fiscal Quarter of 2021 Financial Results. At this time, all participants are in a listen-only mode. Following the formal remarks, we will conduct a question-and-answer session.

[Operator Instructions] Hosting today's conference will be Reed Anderson with ICR. As a reminder, today's conference is being recorded. And now, I would like to turn the conference over to Mr. Anderson. Please go ahead, sir..

Thank you. Good afternoon, and welcome to LifeVantage Corporation's conference call to discuss results for the fourth fiscal quarter of 2021. On the call today from LifeVantage with prepared remarks are Steve Fife, Chief Executive Officer and Chief Financial Officer; and Justin Rose, Chief Sales and Marketing Officer.

By now, everyone should have access to the earnings release, which went out this afternoon at approximately 4:05 p.m. Eastern Time. If you have not received the release, it is available on the Investor Relations portion of LifeVantage's website at www.lifevantage.com.

This call is being webcast, and a replay will be available on the company's website, as well. Before we begin, we would like to remind everyone that our prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions.

These statements do not guarantee future performance and, therefore, undue reliance should not be placed upon them.

These statements are based on current expectations of the company's management and involve inherent risks and uncertainties, including those identified in the Risk Factors section of LifeVantage's most recently filed Forms 10-K and 10-Q.

Please note that, during today's call, we will discuss non-GAAP financial measures, including results on an adjusted basis.

Management believes these financial measures can facilitate a more complete analysis and greater transparency into LifeVantage's ongoing results of operations, particularly when comparing underlying operating results from period to period. We've included a reconciliation of these non-GAAP measures with today's release.

This call also contains time-sensitive information that is accurate only as of the date of this live broadcast, August 19, 2021. LifeVantage assumes no obligation to update any forward-looking projection that may be made in today's release or call.

Now, I will turn the call over to Steve Fife, the Chief Executive Officer and Chief Financial Officer of LifeVantage..

one, predictive functionality that will alert distributors to customers and distributors that are at risk of churning with specific actions the distributor should take to prevent the attrition, two, new features that simplify the sharing of information and content across social media.

Three, we will add tools to support a new Axio sampling strategy that Justin will touch on briefly. And four, we will continue to roll out the app to international markets, including the Philippines, which we will expect to launch in fiscal Q2.

In advance of our latest Elite Academy event, we held a meeting with approximately 200 key leaders and focused on recognition and setting expectations. Our distributors take a prominent role in these pre-event meetings, and their high level of excitement was indicative of the feedback we've been receiving in response to our key initiatives.

Of particular note was the increased confidence many leaders exhibited around their ability to leverage a renewed emphasis on core principles to accelerate growth in their individual businesses. We've also been making progress building out our corporate leadership team. In March, Alissa Neufeld was appointed General Counsel and Corporate Secretary.

Alissa's background in the industry and experience in business and legal roles has been instrumental in strengthening our partnership with key distributors, and sharpening our messaging around communicating our story. In May, Matt Cooley was appointed our Chief Operating Officer.

His 20-plus years of experience in complex key operations and technology leadership roles is playing a big role in our international growth efforts and optimization.

In addition, Matt’s technology background has been most helpful as we continue ramping up the use of our digital tools to drive engagement and enhance the experience for distributors and customers. LifeVantage’s products are uniquely differentiated and backed by over 30 independent research studies from leading institutions around the world.

Health and wellness remains key areas of focus for consumers globally, and the adverse effects of oxidative stress are well-understood. We believe that our refocus on proven efficacy of our core products and addressing these issues along with improved messaging puts us in a strong position to resume growth in fiscal 2022.

Before I turn to a discussion of the fourth quarter results, let me turn the call over to Justin Rose, our Chief Sales and Marketing Officer to discuss our recent activities..

Thank you, Steve, and it's a pleasure to speak with everyone today. Increasing the total number of active accounts remains our primary goal, and we are pleased with recent progress, expecting momentum to continue building gradually throughout fiscal 2022.

The efforts we discussed last quarter to refocus on our core products and to drive renewed engagement in alignment with our distributors are having a positive impact on our results. First, I'll provide you with an update on key action items that we outlined on our last call, aimed at growing customers and distributors.

In the latter part of the second quarter, select top distributors started hosting in-person meetings, as a strategy that has proven effective at driving engagement with current and prospective customers.

Preliminary results are highly encouraging and one example a distributor had approximately 200 people attend the meeting, and 40% of the prospects purchased our flagship enrollment pack.

Over the next several months, we expect in-person meetings to accelerate, reflecting heightened engagement by our top leaders, energized to capitalize on a tighter focus on a sharper message around our core Nrf2 product. Driving second month purchase activity is another important initiative for us.

And the artificial intelligent tools we started implementing a few months ago have proven effective in identifying opportunities for increasing sales and mitigating churn. While it's early and we still are fine tuning our algorithms, having this capability is clearly additive.

We've also started a welcome call campaign as part of an onboarding process for our new customers and distributors, and early results have also been positive. In June, we rolled out our month of action.

It's a distributor incentive program using our proprietary LifeVantage app, which is designed to promote and reward key behaviors proven to drive engagement. We tracked a handful of metrics using the app including contacts added, media shared, shopping carts shared, enrollment link shared and messages sent.

Across all metrics, we saw a significant surge in activity. For example, contacts added was 9 times greater in this month of June versus our low watermark in the prior five months, and 4.5 times the monthly average over the same period.

Media shared was over 4 times higher in June versus the prior five month average, and shopping carts shared were 6 times higher. Finally, enrollment link shared with 3.5 times higher than the monthly average from January to May.

Results from our month of action promotions are illustrative of the renewed level of engagement by our distributors, as well as our ability to utilize the app to help them optimize their income producing activities.

On July 10, we hosted another Elite Academy building on the momentum we've been seeing around distributor engagement and alignment, as well as our repositioning around Nrf2, our core foundational product and key point of differentiation.

Focus areas during the Elite Academy included the ITT system, which is our sales process, along with tools and activities designed to help increase enrollments and retention.

The event was well attended with over 3,000 registrations and many distributors hosting their own viewing parties, which helped broaden and amplify the message throughout the U.S. and Canada. This month, we rolled out two simplified enrollment packs in addition to our $50 starter kit.

The Elite pack which is priced at $999 includes one of every product as well as duplicates of our top selling items, so new distributors can start building their business from day one. It also includes access to our top training programs and upcoming events, which collectively boost a true value of the Elite pack of around $2,200.

The premier pack is our secondary offering and it's priced at $299, and it includes our core products. The daily wellness product we launched at the end of March and the CBD enhanced Nrf2 personal care line we launched at the beginning of June have been well received and are picking up momentum.

The Axio flavors we launched in Q4 were a big success and we've seen significant follow through from distributors, ramping up their commitments for additional orders. We launched an Axio sample kit this week. That will make it even easier for new customers to try different flavors. What's unique about Axio is the benefits are immediate.

I know from personal experience that shortly after taking Axio, I quickly noticed increased mind clarity and energy. This makes it a great combination with our core Nrf2 product amplifying the results.

We added strawberry splash and purple grape flavors to our permanent flavor offerings in the fourth quarter, and we launched lemonade as a seasonal flavor and have plans to launch an additional flavor for the fall. Our website is getting a refresh, with full deployment expected in October. Currently, the new homepage is live.

The refresh will include considerable upgrades to imaging and sharper refocus messaging around our core product Protandim Nrf2, as well as LifeVantage’s overall positioning within health and wellness. We're also gearing up for our global convention in October, which will be a hybrid event this year versus 100% virtual in 2020.

We estimate that last year we had participation from over 20,000 people from 18 different countries. This year, we have room to accommodate 2,500 in-person attendees, and early indications are highly encouraging for both in-person and virtual attendance.

The significance of this event along with the return of other in-person activities cannot be understated relative to driving growth in fiscal 2022 and beyond. Finally, I'm also very excited about our planned launch in the Philippines, which is targeted during our fiscal second quarter.

There's a ton of energy and excitement from our leadership in that region. It's an area that sets up well for our business model, and we expect to leverage the significant experience of our team to develop this market. Now, let me turn the call back over to Steve, to run through the fourth quarter financial results..

Thank you, Justin. Let me walk you through our fourth quarter financials. Please note, I will be discussing our non-GAAP adjusted results. You can refer to the GAAP to non-GAAP reconciliations in today's press release for additional details. Fourth quarter revenue was $54.8 million down 7.7% on a year-over-year basis.

Revenue in the Americas declined 9.6% to $37.7 million, primarily reflecting a 9.8% decrease in total active accounts, primarily in the U.S. This decrease was partially offset by modest increases in both average revenue per account and retention in the region.

In Asia Pacific and Europe, fourth quarter revenue decreased 3.3% year-over-year to $17.1 million with total active accounts up 8.5%, the benefit of which were offset by decreases in average revenue per account, primarily in our Greater China region.

Japan revenues were down 3.6% versus last year, reflecting continued restrictions and due to COVID-19. Results in Australia and New Zealand were strong up 44.6% compared to last year's fourth quarter due to new leadership in the region. Gross margin was 82.1% in the fourth quarter compared to 84.1% a year earlier.

The decrease in gross margin was driven primarily by increased shipping to customer expenses due to COVID-19, decreased fee revenues from fewer in-person events and shifts in geographic and product sales mix.

Commission and incentive expenses as a percentage of revenue decreased by 200 basis points year-over-year to 46.7%, reflecting changes in the timing and magnitude of promotional activities. Adjusted SG&A declined $700,000 to $13.6 million due to lower stock and incentive compensation expense.

Adjusted operating income was $5.8 million or 10.6% of revenue compared to $6.7 million or 11.3% of revenue for the prior year period. Adjusted net income was $4.3 million or $0.31 per fully diluted share compared to $4.1 million or $0.28 per fully diluted share for the prior year period.

The company's effective tax rate was 24.3% in the fourth quarter of fiscal 2021 compared to 37.2% in the prior year period. The decrease in the current quarter tax rate was attributable to limited unfavorable book to tax differences in the current year period versus the prior year quarter.

The decrease in tax rate positively impacted adjusted earnings per share by approximately $0.05. For fiscal year 2022, we expect our tax rate will be approximately 26% versus our full year 2021 tax rate of approximately 24%. Adjusted EBITDA for the fourth quarter was $6.6 million, a decrease of $1.6 million from the prior year period.

Please note, that all of the adjustments from GAAP to non-GAAP I discussed today are reconciled in our earnings press release issued this afternoon. We ended the fourth quarter in a strong financial position with $23.2 million of cash and no debt.

And we continue to maintain $5 million of availability under our revolving line of credit, which was renewed for an additional three years on April 1 of 2021. We used $3.9 million in cash during the fourth quarter of fiscal 2021 to repurchase approximately 480,000 shares of common stock under our share repurchase authorization.

As of June 30, 2021, there remains $11.5 million available under the authorization. We expect to continue to be active with our share repurchase efforts in the future. Capital expenditures totaled $3.7 million in fiscal year ending June 30, 2021, primarily for building out our new office space and further development of our digital technologies.

Turning to our fiscal 2022 outlook, we anticipate our fiscal 2022 revenue to be $225 million to $235 million, and adjusted non-GAAP EBITDA in the range of $22 million to $24 million, with adjusted non-GAAP earnings per share in the range of $0.83 to $0.87.

In summary, we made progress on key initiatives in the fourth quarter, and are encouraged by recent trends in activity and engagement by our top distributors.

We believe this sequential increase in active accounts during the fourth quarter supports our view that momentum is building, which should drive improvements in revenue and earnings during fiscal 2022.

Consumers' interest in health and wellness is as strong as ever, and we have a broad portfolio of high-quality, innovative products proven to help optimize health and improve performance at all stages of life. Our corporate team and distributor leadership are aligned. Our financial condition is solid with a strong cash position and profitability.

And we remain committed to driving value for all stakeholders. Now, let me turn the call back to the operator to facilitate questions.

Operator?.

Ladies and gentlemen, we will now have our question-and-answer session. [Operator Instructions] First question comes from Doug Lane with Lane Research. Please proceed with your question..

Yes. Hi, good afternoon, everybody. Looking at the 2022 guidance, the revenue looks to be up mid-single digits at the midpoint.

I'm wondering what you're contemplating for distributor trends along with the revenue growth, because the distributor trends have been somewhat weak, not really seeing a term there yet? How do you expect distributor growth to play out in 2022?.

Yeah, Doug, this is Steve. We've got a number of things lined up to drive distributor enrollments and growth. We started this year with really two primary goals and support an overall focus on increasing our active accounts.

The first goal is focused on distributor enrollments and then the second really ties to retention, but it's aligned around the second order purchases specifically. And from a distributor standpoint, we think that getting back to the in-person events is going to be critical for that.

Our distributors, a good portion of them dealt very traditionally not necessarily in their living rooms, but in medium-sized group gatherings. And those meetings have already started to take place. We've had a few of them. We have groups coming into our new office.

And, between now and our October convention, we have several lined up both to reengage the distributors, as well as further corporate team to help support them as they put new prospects in those rooms. So, that's one of the biggest things.

And I think our kind of refocusing back on our core opportunity and led by, Protandim Nrf2 our flagship product, it's a product that's unparalleled with others in the industry, and frankly, it's just in the world, and allowing them to tell that story and utilizing that unique product, in terms of them engaging in the business opportunity are two things that really is what propelled the company back in our growth spurt.

And so reengaging and supporting them along those two lines, I think are the biggest opportunities we have. We don't anticipate a lot of growth from our average revenue per account in fiscal ‘22.

So, the growth to that midpoint, which is around 6% is really focused on increasing the total number of accounts, both distributors -- and as we focus on distributors, we know that customers come..

Okay, fair enough. And just secondly, looking at your adjusted EBITDA outlook, it's down from this year, despite the positive sales outlook.

So where specifically, are you seeing potential margin pressure going in this year?.

Yeah, our gross margins, even from ‘20 to ‘21, we talked about are down, a point to two points, primarily driven by increased supply chain costs. And, our forecast for ‘22 doesn't anticipate that that will continue into the year. So, we do see continued modest pressure on our gross margins, clearly not returning to the fiscal ‘20 levels.

But we also see -- we're anticipating increased investment, especially in our G&A area to support the revenue growth. Going back to live events, we benefited in fiscal ‘21 by not having those events from a G&A standpoint we know that it adversely affected our top-line revenue from a SG&A standpoint. We didn't incur those costs.

And, we're also investing, Justin mentioned, investment in our website, and other marketing tools to again, further support our distributors. So, the increase in our G&A is largely going to support our revenue growth..

Okay, that makes sense. Thanks, Steve..

Great. Thanks, Doug..

Thank you. [Operator Instructions] Our next question comes from Jim Galloway, a private investor. Pleased proceed with your questions..

Thank you for taking my call. I'm very pleased to see that we're focusing back on the core products and Protandim. Wondering, are there any new studies that you see reaching the marketplace, because most of our studies are outdated? The facts are still the same.

But is anyone researching the benefit of Nrf2 these days that may help us?.

Hey, Jim, this is Justin. Thanks for the question. Yeah, we have some incredible studies. And I think you're going to see even some of our past studies a little bit more prevalent in our communications coming up.

But we are putting a big emphasis this next fiscal year on getting back to some of those not only studies but just notices throughout different publications and things that our distributors can turn to, to utilize, to give them a reason to get excited about our story again. So it is part of our strategy moving forward.

So I think we're thinking very much aligned there..

Thank you. One last question, the stock market's been going well. We've been not so well. One of the reasons that people do stock repurchases is to improve the value of the stock.

Justin, what would $11.9 million do to help you in marketing and growing the company to be spent that way rather than on stock buyback?.

Yeah, it's a good question, Jim, and one that we ask ourselves, if not daily, weekly, for sure. We continue to look for opportunities to invest further in the business, and by that I don't just mean M&A opportunities, although, we are active in looking at the ability to grow the business inorganically.

But like I just mentioned, in response to Doug's question, we're investing several millions of dollars this next year to drive growth strategies for the business. We're consciously doing that. We're prepared to take a bit of a hit on the EBITDA this next year, in anticipation of building a stronger foundation for future growth.

The business still generates a lot of cash, we'll still be very cash flow positive, even after the investments that we plan on making in fiscal ‘22. So we look at that, I think this year, you'll see more activities in terms of building organically. We'll continue to do stock buybacks as we feel like the stock is undervalued at its current level.

So it is an appropriate use of cash. But we continue to look at ways to provide even a higher return on that cash that we generate..

Okay. I'm pleased to see we're going back into the Philippines. I remember when we were there, what, three, four or five years ago, and I thought it was going to be a pretty good market for us. So congratulations on restarting the Philippines.

China was supposed to be growing a little bit, but I know the relationship with China is not too good between the United States now.

Is that affecting our business there?.

Yeah, Jim, this is Justin again. First of all, with the Philippines, yeah, we definitely have a lot of energy and excitement. The first time that we were in the Philippines, we were just there as a not for resale model.

So this time going in fully, giving our distributors an opportunity to build there is I think going to truly make a big difference from even the experience the first time.

And then when it comes to China, yeah, we're going in with an e-commerce model, and so it is a little bit different than I think what some of our competitors that have direct sales licenses are doing right now. And we have not felt too much of a difference in the past little while with the relationship between the U.S. and China.

We have seen the e-commerce model start to pick up some momentum here in the last few months, and are very encouraged by the leaders that we have engaged right now that are really pushing that e-commerce model as it's out currently. When it comes to Taiwan, they've had a tough run, especially with the COVID situation.

We really run that business through our office there. Most people come in and place orders in office and not having the ability to do that as freely as they have in the past has definitely taken a little bit of toll there as well..

Well, I'm relying on you guys and not selling my shares. So, good luck..

All right, appreciate it, Jim..

Thank you. There are no further questions at this time. I'd like to turn the floor back over to Steve Fife, for any closing remarks..

Thank you for joining us today. In closing, I want to take the opportunity to thank all of our employees for their hard work and dedication, as well as our outstanding team of distributors. We remain confident in our business model and are focused on delivering the LifeVantage products our customers depend on.

We hope you all stay safe and healthy, and look forward to updating you on our next call. Have a great day..

Ladies and gentlemen, this concludes today's webcast. You may now disconnect your lines at this time. Thank you for your participation, and have a great day..